ELOX · Eloxx Pharmaceuticals
AI read · Good for ELOX
The AI's read
The findings give Eloxx early evidence that exaluren reaches its intended target, and the reported safety results add support. Only 3 people took part, so the study cannot show whether patients will gain lasting kidney benefits. Still, it supports testing exaluren in the ongoing Phase 2b study.